NTRB Nutriband Inc: Net earnings per share for the last 12 months

Nutriband Inc. (NTRB) relies on third-party manufacturing capacities to scale production while minimizing operational disruptions. However, geopolitical tensions and trade barriers could complicate component delivery and product certification. This price chart reflects an EPS (TTM) of 79.90. The business generates revenue through the licensing of exclusive transdermal drug delivery methods, securing a long-term income stream.
NTRB (Nutriband): analytical breakdowns and indicator data

This indicator measures the percentage change in earnings per share over twelve months, utilizing daily data snapshots to eliminate lags between quarterly reports. By analyzing the annual trend of the EPS TTM metric, investors assess the monetization efficiency of the AVERSA technology in combating the opioid crisis, where growth in this metric confirms the commercial success of Nutriband Inc. (NTRB) protected transdermal systems.